Auris Health Stock

aurishealth.comHealthcare / Medical DevicesFounded: 2007Funding to Date: $738.23MM

Hansen Medical is a developer and manufacturer of flexible robotic technology built for multi-specialty, peripheral vascular robotics procedures.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Auris Health before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Auris Health Stock Price

Forge Price 1
Price no longer available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Auris Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
11/28/2018 Series D-1 $220.42MM $xx.xx $2.13B D1 Capital Partners, Lux Capital, Mithril Capital Management, Partner Fund Management, Senator Investment Group, Viking Global Investors, Wellington Management
Price per Share
$xx.xx
Shares Outstanding
1,049,120,408
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
D1 Capital Partners, Lux Capital, Mithril Capital Management, Partner Fund Management, Senator Investment Group, Viking Global Investors, Wellington Management
08/04/2017 Series D $280.2MM $xx.xx $1.25B Coatue Management, Highland Capital, Lux Capital, Mithril Capital Management, Partner Fund Management, Section 32, Viking Global Investors
Price per Share
$xx.xx
Shares Outstanding
1,796,153,846
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Coatue Management, Highland Capital, Lux Capital, Mithril Capital Management, Partner Fund Management, Section 32, Viking Global Investors
08/09/2016 Series C $198.58MM $xx.xx $600.79MM Korea Investment Partners, Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,738,911,252
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Korea Investment Partners, Undisclosed Investors
03/31/2014 Series B $33MM $xx.xx $63.9MM Highland Capital Partners, Lux Capital, Mithril Capital Management, Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,709,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Highland Capital Partners, Lux Capital, Mithril Capital Management, Undisclosed Investors
08/08/2012 Series A-2 $1.38MM $xx.xx $16.5MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
148,106,471
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
08/02/2012 Series A-1 $3MM $xx.xx $24.6MM Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap
Price per Share
$xx.xx
Shares Outstanding
294,117,647
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap
12/22/2011 Series A $1.64MM $xx.xx $9.48MM Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap
Price per Share
$xx.xx
Shares Outstanding
176,795,153
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fast Forward, Highland Capital Partners, Kleiner Perkins, Medcap

Leadership & Board

Leadership

David Styka
CFO
Josh DeFonzo
President
David Mintz
Vice President of Research & Development
Frederic Moll
Co-Founder, Chief Executive Officer & Board Member
David Schummers
Vice President, Marketing

Board

Ajay Royan
Mithril Capital Management
Robert Kerrey
Self
Cameron Marlow
Facebook
Peter Hébert
Lux Capital
Bijan Salehizadeh MD
NaviMed Capital
Frederic Moll
Auris Surgical Robotics

Auris Health stock FAQs

plusminus

Can you buy Auris Health stock?

You can no longer buy Auris Health stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy Auris Health stock?

You can no longer buy Auris Health stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Auris Health stock?

You can no longer sell stock of Auris Health on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell Auris Health stock?

You can no longer sell stock of Auris Health on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is Auris Health a public company?

Auris Health is now a public company.
plusminus

What is Auris Health’s stock price?

The stock price of Auris Health is not currently available.
plusminus

What is Auris Health’s stock ticker symbol?

The ticker symbol of Auris Health is not currently available.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Auris Health’s News and Media Highlights

Johnson & Johnson’s robotic surgery and medical device division, Ethicon, is dropping $3.4 billion in cash to pick up Auris Health, a developer of robotic diagnostics and surgical devices initially focused on detecting and treating lung cancer. The healthcare giant said an additional $2.3…
Robotic surgery hasn't necessarily helped patients, but it's made surgeons' work more "gadget-oriented."
Johnson & Johnson is pursuing an acquisition of surgical robotics firm Auris Hea...
Dublin, Jan. 16, 2019 (GLOBE NEWSWIRE) -- The "Medical Robots - Market Analysis, Trends, and
Updated on: Nov 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.